ArticleTherapeutic advances in medical oncology2024

Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitors.

Liang-Yun Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.